Rui Fu
@ruifu66
Lung Cancer Researcher & Thoracic Cancer Surgeon from Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital. IASLC Committee Member.
ID: 1348666968258220038
11-01-2021 16:24:10
77 Tweet
126 Takipçi
460 Takip Edilen
✅ Redoing Tony Mok Q after update on FLAURA-2: How much chemotherapy is needed added on top of #osimertinib to obtain the benefit of the combination? Would short course induction therapy w/o maintenance pemetrexed be enough? ⬇️ Adherence on trial to pemetrexed #ELCC24 ESMO - Eur. Oncology
Exploratory #ctDNA analysis of the FLAURA2 trial by Pasi Jänne Dana-Farber #AACR24 👉 Comparable EGFR mutation clearance in ctDNA at 6 weeks, in both arms. EGFR Resisters #LCSM
FLAURA2- Baseline detection of ctDNA may identify a subgroup of pts who derive most benefit from addition of chemoT to osimertinib as first line trtt for EGFRmut NSCLC by P.Jänne at #AACR24 EGFR Resisters Dana Farber's EGFR-Mutant Lung Cancer Center Gustave Roussy Dana-Farber News
Outstanding talk covering locally advanced and oligometastatic lung cancer from incoming School of Medicine Trinity St James's Cancer Institute Marie Curie Prof. Gerry Hanna #ailcc24 #lcsm
#LCSM 🫁CA colleagues, IASLC Career Development Committee will have a pre-conference workshop on IASLC grant💰application at #WCLC24. We have a list of fantastic faculty for this interactive workshop. If you're going to #WCLC24, pre sign-up for a spot! cattendee.abstractsonline.com/meeting/20598/…